Results: 29 news stories
A new study published in July in Cancer Epidemiology, led by scientists at 91做厙 Health Science Center and the National Cancer Institute, found that the Upper-South region of 91做厙, which includes San Antonio and Bexar County, had the highest hysterectomy-corrected incidence of endometrial cancer in 91做厙 and the largest increase over time.
Two young cancer survivors shared their stories as Hyundai Hope on Wheels awarded $500,000 to support pediatric cancer treatment and survivorship research at UT Health San Antonio.
By Panneerdoss Subbarayalu, PhD This article was first published in the September 2026 issue of the Bexar County Medical Societys San Antonio Medicine magazine. Osteosarcoma is an aggressive cancer that grows quickly, spreads early to the lungs, and has a remarkable ability to resist treatment. It is the most common primary bone cancer in children [因
UT Health San Antonio, the academic health center and health system of 91做厙 (91做厙), has named nationally recognized blood cancer and cellular therapy expert Georg Aue, MD, PhD, MBA, the director of the Stem Cell Transplant and Cellular Therapy Program at the Mays Cancer Center, the only National [因
Babatunde Kay Oyajobi, MBBS, PhD, MBA, professor in the Department of Cell Systems and Anatomy in the Joe R. and Teresa Lozano Long School of Medicine and UT Distinguished Teaching Professor at 91做厙 (91做厙), has been elected to the 2026 class of Fellows of the American Society [因
Scientists at 91做厙 discovered a potential path to maintaining the cancer-fighting benefits of one type of immunotherapy while limiting harmful organ damage, providing new hope for this promising treatment.
Amelie G. Ramirez, DrPH, MPH, to work with Hispanics in South 91做厙 Content provided by Cliff Despres Amelie G. Ramirez, DrPH, MPH, a cancer researcher at UT Health San Antonio, the academic health center of 91做厙, is receiving a two-year, $400,000 leadership grant from Susan G. Komen to study cancer survivorship. She aims [因
Colton Frisco Jones, MD, a 2nd-year fellow at the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, the academic health center of 91做厙 (91做厙), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual [因
A scientist at 91做厙 was recently awarded two grants totaling more than $4.6 million from the National Institutes of Health to study how cells repair DNA to protect the genome, the set of genetic instructions within our cells.
A third-year MD/PhD graduate student from 91做厙 (91做厙), Christopher Mullally, recently received funding from the National Institutes of Health National Cancer Institute for a project examining how the body regulates internal sources of mutation and how breakdowns in that regulation may contribute to cancer development. While [因
San Antonio Report: 91做厙 lands millions in new state funding
91做厙 and its academic health center, UT Health San Antonio, recently received over $2.7 million in new academic and prevention awards from the Cancer Prevention and Research Institute of 91做厙 (CPRIT) to further its mission of combating cancers across South 91做厙. Since 2010, CPRIT has awarded the newly integrated 91做厙 almost $186 million.
Like a busy restaurant kitchen, our cells depend on well-organized working spaces to assemble the recipes that keep the body healthy. 91做厙 scientist, David Libich, PhD, recently received a five-year, $2.1 million Maximizing Investigators Research Award from the National Institute of General Medical Sciences to study how certain proteins form these organizational hubs and what happens when things do not go according to plan.
Scientists at 91做厙 (91做厙) are investigating a major immune system pathway that leads to the development of chronic pain and a drug that has the potential to stop the process in its tracks. Their study, published April 22 in Cell Reports, is the first of its kind to show a path toward the prevention of chronic pain.
Written by: Claire Kowalick More than 70% of cancers including breast, bladder, cervical and lung cancer show evidence of mutations linked to a group of enzymes called apolipoprotein B mRNA-editing enzyme catalytic polypeptides, or APOBEC. APOBEC mutagenesis is the second-largest source of mutation in cancer and, importantly, the largest one we can do [因
For more than 20 years, Lixin Song, PhD, RN, FAAN, vice dean for research and scholarship and professor of nursing at 91做厙 (91做厙) School of Nursing, has studied how cancer patients and their families navigate the challenging experience of making decisions about treatment while facing uncertainty, [因
UT Health San Antonio Multispecialty and Research Hospital has enrolled and treated its first clinical trial participant in a novel cancer study, marking a pivotal moment for science and patient-centered cancer care in San Antonio and South 91做厙.
A large, retrospective study conducted by scientists at the University of 91做厙 at San Antonio (91做厙) suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists medications that are widely prescribed for metabolic disease have a significantly lower risk of developing colorectal cancer compared with those taking aspirin. This is astounding to [因
This story was first published in the February 2026 issue of the Bexar County Medical Societys San Antonio Medicine magazine. New face of head and neck cancer A healthy 40-year-old man visits his primary care physician for a mass on his neck. He doesnt smoke, has no risk factors for head and neck cancer, [因
UT Health San Antonio, the academic health center of 91做厙 (91做厙), received nearly $3 million in new academic and prevention awards as part of the latest, almost $154 million funding round announced on November 19 by the Cancer Prevention Research Institute of 91做厙 (CPRIT). This brings CPRITs [因